Cytotoxic products for Hillingdon Hospital's pharmacy come from Baxter
- The Hillingdon Hospitals NHS Foundation Trust
- London
- Open procedure, 2 bids
- 1 July 2026 to 30 June 2029
The Hillingdon Hospitals NHS Foundation Trust is buying patient-specific cytotoxic and adjuvant products from Baxter Healthcare for its hospital pharmacy.
Each product is prepared for an individual patient and delivered to the Pharmacy Department at Hillingdon Hospital in Uxbridge, as the trust needs it. Bids were scored 60% on technical quality, 30% on commercial terms and 10% on social value.
Two firms bid in an open tender. The trust made the award in May 2026 at £9.3m, more than a third above its £6.7m estimate. It runs for three years, with two optional one-year extensions to June 2031.
Contract ends June 2029
- What
- Aseptic compounding, specials and contract pharmaceutical manufacturing
- Supplier
- Baxter Healthcare
- Value
- £9.29m
- How it was bought
- Open procedure
- 2 bids
- Dates and next
- Jul 2026 to Jun 2029
- Option to Jun 2031